| Tocilizumab in hospitalized patients with severe Covid-19 pneumonia IO Rosas, N Bräu, M Waters, RC Go, BD Hunter, S Bhagani, D Skiest, ... New England Journal of Medicine 384 (16), 1503-1516, 2021 | 1137* | 2021 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 486 | 2021 |
| Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis CC Quarta, E Gonzalez-Lopez, JA Gilbertson, N Botcher, D Rowczenio, ... European heart journal 38 (24), 1905-1908, 2017 | 209 | 2017 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 195 | 2021 |
| Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases S Nanthapisal, C Murphy, E Omoyinmi, Y Hong, A Standing, S Berg, ... Arthritis & Rheumatology 68 (9), 2314-2322, 2016 | 168 | 2016 |
| Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue … DF Hutt, M Fontana, M Burniston, AM Quigley, A Petrie, JC Ross, J Page, ... European Heart Journal-Cardiovascular Imaging 18 (12), 1344-1350, 2017 | 158 | 2017 |
| Large-vessel vasculitis D Pugh, M Karabayas, N Basu, MC Cid, R Goel, CS Goodyear, ... Nature Reviews Disease Primers 7 (1), 93, 2021 | 118 | 2021 |
| International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors T Youngstein, P Hoffmann, A Gül, T Lane, R Williams, DM Rowczenio, ... Rheumatology 56 (12), 2102-2108, 2017 | 117 | 2017 |
| Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre T Lane, JH Pinney, JA Gilbertson, DF Hutt, DM Rowczenio, S Mahmood, ... Amyloid 24 (3), 162-166, 2017 | 97 | 2017 |
| Optimizing the outcome of vascular intervention for Takayasu arteritis AH Perera, T Youngstein, RGJ Gibbs, JE Jackson, JH Wolfe, JC Mason Journal of British Surgery 101 (2), 43-50, 2014 | 97 | 2014 |
| Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome DM Rowczenio, S Pathak, JI Arostegui, A Mensa-Vilaro, E Omoyinmi, ... Blood, The Journal of the American Society of Hematology 131 (9), 974-981, 2018 | 92 | 2018 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 88 | 2023 |
| Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study … A Abhishek, RJ Boyton, N Peckham, Á McKnight, LC Coates, J Bluett, ... The Lancet Respiratory Medicine 10 (9), 840-850, 2022 | 69 | 2022 |
| Cyberattack on Britain's National Health Service-A Wake-up Call for Modern Medicine. R Clarke, T Youngstein The New England journal of medicine 377 (5), 409-411, 2017 | 65 | 2017 |
| Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis T Youngstein, JE Peters, SS Hamdulay, D Mewar, A Price-Forbes, ... Clin Exp Rheumatol 32 (3 Suppl 82), S11-18, 2014 | 63 | 2014 |
| Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis R Manwani, D Foard, S Mahmood, S Sachchithanantham, T Lane, ... Haematologica 103 (4), e165, 2018 | 61 | 2018 |
| Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial REMAP-CAP Investigators, LPG Derde, AC Gordon, PR Mouncey, ... MedRxiv, 2021.06. 18.21259133, 2021 | 59 | 2021 |
| Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic E Price, E MacPhie, L Kay, P Lanyon, B Griffiths, C Holroyd, A Abhishek, ... Clinical Medicine 20 (3), 256-261, 2020 | 53 | 2020 |
| Novel angiographic scores for evaluation of large vessel vasculitis E Tombetti, C Godi, A Ambrosi, F Doyle, A Jacobs, AP Kiprianos, ... Scientific reports 8 (1), 15979, 2018 | 46 | 2018 |
| Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor T Rezk, HJ Lachmann, M Fontana, S Sachchithanantham, S Mahmood, ... Kidney International 92 (6), 1476-1483, 2017 | 41 | 2017 |
